Prescription Treatment with ZYTIGA® (abiraterone acetate)

METASTATIC PROSTATE CANCER.

ZYTIGA^® (abiraterone acetate) is a prescription medicine that is used along with prednisone. ZYTIGA^® is used to treat men with prostate cancer that has spread to other parts of the body. ZYTIGA^® is not for use in women. It is not known if ZYTIGA^® is safe or effective in children.

Is ZYTIGA^® Right for You?

LEARN MORE

PAYING FOR ZYTIGA^®

SEE COST SUPPORT OPTIONS

HOW ZYTIGA^® WORKS

SEE COST SUPPORT OPTION

This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. The material on this site is intended only as informational or as an educational aid and it is not intended to be taken as medical advice. The ultimate responsibility for patient care resides with a healthcare professional.

This information is intended for the use of patients and caregivers in the United States and Puerto Rico only. Laws, regulatory requirements, and medical practices for pharmaceutical products vary from country to country. The Prescribing Information included here may not be appropriate for use outside the United States and Puerto Rico.

Third party trademarks used herein are trademarks of their respective owners.

RETIREMENT WON’T CHANGE WHO HE IS.

METASTATIC PROSTATE CANCER.

PAYING FOR ZYTIGA^®

HOW ZYTIGA^® WORKS

Selecting the Right Treatment

RETIREMENT WON’T CHANGE WHO HE IS.

METASTATIC PROSTATE CANCER.

PAYING FOR ZYTIGA®

HOW ZYTIGA® WORKS

Selecting the Right Treatment

PAYING FOR ZYTIGA^®

HOW ZYTIGA^® WORKS